S S Burtles

1.3k citations
17 papers · 1.1k · 1 hit paper · h-index 12

Impact in

Papers in

    • T-cell and B-cell Immunology 4
    • Immunotherapy and Immune Responses 3
    • Pancreatic function and diabetes 2

S S Burtles

17 papers receiving 1.1k citations

S S Burtles's Hit Papers

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. 1999 · 574 citations
5740+9+18Years since publication100200300400500

Peers

S S Burtles
Comparison fields: 5 of 91
  • Biomaterials 541
  • Polymers and Plastics 99
  • Biomedical Engineering 304
  • Immunology 145
  • Oncology 185
Replace Ayelet David with:
Ayelet David Israel
Charles Engbers United States
Jurstine Daruwalla Australia
Jonathan D. Ashley United States
Alberto Gabizon Israel
Sharon A. Johnstone Canada
Olivier Meyer United States
Grzegorz Pietrzyński Poland
Jennifer I. Hare United Kingdom
Nikki Parker United States
S S Burtles relative to Ayelet David Israel Ayelet David's profile →
Citations per field
00.5×1.5×
Ayelet David · 1×
Citations per year

Countries citing papers authored by S S Burtles

Since Specialization
Citations

This map shows the geographic impact of S S Burtles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S S Burtles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S S Burtles more than expected).

Fields of papers citing papers by S S Burtles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S S Burtles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S S Burtles. The network helps show where S S Burtles may publish in the future.

Co-authors

The 25 scholars most cited alongside S S Burtles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S S Burtles Line = papers co-authored together S S Burtles links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.
Hit paper breakdown →
1999574
2 2002214
3
Primary and secondary human in vitro T-cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms.
199269
4 199859
5 199943
6 199437
7 200416
8 199216
9 199314
10 200212
11 200312
12 198411
13 199010
14 20177
15
The effect of neonatal tolerance to bovine gamma globulin (BGG) on BGG-reactive CD4+ T lymphocytes.
19924
16 20033
17 19921

About S S Burtles

S S Burtles is a scholar working on Immunology, Surgery, Oncology, Computational Theory and Mathematics and Genetics, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), T-cell and B-cell Immunology (4 papers), Computational Drug Discovery Methods (3 papers), Diabetes and associated disorders (3 papers), Immunotherapy and Immune Responses (3 papers), Pancreatic function and diabetes (2 papers), Cancer therapeutics and mechanisms (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Biomaterials (541 citations), Polymers and Plastics (99 citations), Biomedical Engineering (304 citations), Immunology (145 citations) and Oncology (185 citations). S S Burtles has collaborated with scholars based in United Kingdom, Netherlands and Belgium. Frequent co-authors include Ruth Duncan, T. Murray, Lilian S. Murray, Peter D. Wilson, Chris Twelves, Rachel Morrison, T. E. Hilditch, Daniela Fraier, E. Frigerio and J Cassidy. Their work appears in journals such as British Journal of Cancer, The Journal of Immunology, Neurochemical Research, Journal of Clinical Oncology and Journal of Autoimmunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact